Literature DB >> 20676650

MBD4 gene is associated with rheumatoid arthritis in Chinese patients in Taiwan.

Chung-Ming Huang1, Po-Hao Huang, Chi-Lan Chen, Lei Wan, Chang-Hai Tsai, Su-Ching Liu, Wen-Liang Huang, Fuu-Jen Tsai.   

Abstract

This study examines whether or not MBD4 polymorphism is a marker for rheumatoid arthritis (RA) susceptibility or severity for Chinese patients in Taiwan. This study included 193 patients with RA, while 190 unrelated healthy individuals living in Central Taiwan served as controls. The relationship between MBD4 polymorphism and clinical manifestations of RA was evaluated. For the genotype and allelic frequency of MBD4-1057 polymorphism, there were no statistically significant differences between patients with RA and controls. There were significant differences in the distribution of MBD4-8666 polymorphism frequencies between patients with RA and controls [P = 0.013; P (corrected) (Pc) = 0.039]. There were also significant relationships in the distribution of MBD4-9229 polymorphism genotype between patients with RA and controls (P = 0.007; Pc = 0.021). However, we did not detect any associations for MBD4-1057, MBD4-8666 or MBD4-9229 with rheumatoid factor presence, extra-articular involvement or bone erosion in patients with RA. Results suggest that MBD4-8666 and MBD4-9229, but not MBD4-1057, gene polymorphisms are related to RA in Chinese patients in Taiwan.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20676650     DOI: 10.1007/s00296-010-1545-8

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  32 in total

Review 1.  Genomic imprinting: parental influence on the genome.

Authors:  W Reik; J Walter
Journal:  Nat Rev Genet       Date:  2001-01       Impact factor: 53.242

2.  The DNA repair gene MBD4 (MED1) is mutated in human carcinomas with microsatellite instability.

Authors:  A Riccio; L A Aaltonen; A K Godwin; A Loukola; A Percesepe; R Salovaara; V Masciullo; M Genuardi; M Paravatou-Petsotas; D E Bassi; B A Ruggeri; A J Klein-Szanto; J R Testa; G Neri; A Bellacosa
Journal:  Nat Genet       Date:  1999-11       Impact factor: 38.330

3.  Identification of genetic variants in base excision repair pathway and their associations with risk of esophageal squamous cell carcinoma.

Authors:  Bingtao Hao; Haijian Wang; Kaixin Zhou; Yi Li; Xiaoping Chen; Gangqiao Zhou; Yunping Zhu; Xiaoping Miao; Wen Tan; Qingyi Wei; Dongxin Lin; Fuchu He
Journal:  Cancer Res       Date:  2004-06-15       Impact factor: 12.701

Review 4.  Rheumatoid arthritis. Pathophysiology and implications for therapy.

Authors:  E D Harris
Journal:  N Engl J Med       Date:  1990-05-03       Impact factor: 91.245

Review 5.  Imprinting and the initiation of gene silencing in the germ line.

Authors:  M A Surani
Journal:  Cell       Date:  1998-05-01       Impact factor: 41.582

6.  Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis.

Authors:  B Richardson; L Scheinbart; J Strahler; L Gross; S Hanash; M Johnson
Journal:  Arthritis Rheum       Date:  1990-11

7.  Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis.

Authors:  W Lei; Y Luo; W Lei; Y Luo; K Yan; S Zhao; Y Li; X Qiu; Y Zhou; H Long; M Zhao; Y Liang; Y Su; Q Lu
Journal:  Scand J Rheumatol       Date:  2009       Impact factor: 3.641

8.  Enhanced CpG mutability and tumorigenesis in MBD4-deficient mice.

Authors:  Catherine B Millar; Jacky Guy; Owen J Sansom; Jim Selfridge; Eilidh MacDougall; Brian Hendrich; Peter D Keightley; Stefan M Bishop; Alan R Clarke; Adrian Bird
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

9.  Upregulated expression and function of integrin adhesive receptors in systemic lupus erythematosus patients with vasculitis.

Authors:  T Takeuchi; K Amano; H Sekine; J Koide; T Abe
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

10.  Hydralazine and procainamide inhibit T cell DNA methylation and induce autoreactivity.

Authors:  E Cornacchia; J Golbus; J Maybaum; J Strahler; S Hanash; B Richardson
Journal:  J Immunol       Date:  1988-04-01       Impact factor: 5.422

View more
  1 in total

1.  The Mbd4 DNA glycosylase protects mice from inflammation-driven colon cancer and tissue injury.

Authors:  Amy Marie Yu; Jennifer A Calvo; Suresh Muthupalani; Leona D Samson
Journal:  Oncotarget       Date:  2016-05-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.